1. Home
  2. WTBA vs LCTX Comparison

WTBA vs LCTX Comparison

Compare WTBA & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Bancorporation

WTBA

West Bancorporation

HOLD

Current Price

$22.19

Market Cap

375.9M

Sector

Finance

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.66

Market Cap

407.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTBA
LCTX
Founded
1893
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
375.9M
407.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WTBA
LCTX
Price
$22.19
$1.66
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$23.50
$4.67
AVG Volume (30 Days)
29.6K
1.2M
Earning Date
01-29-2026
03-09-2026
Dividend Yield
4.48%
N/A
EPS Growth
49.53
N/A
EPS
1.90
N/A
Revenue
$91,783,000.00
$10,816,000.00
Revenue This Year
$27.90
$6.32
Revenue Next Year
$13.86
$124.49
P/E Ratio
$11.76
N/A
Revenue Growth
19.66
24.05
52 Week Low
$17.31
$0.37
52 Week High
$24.27
$2.09

Technical Indicators

Market Signals
Indicator
WTBA
LCTX
Relative Strength Index (RSI) 47.16 46.12
Support Level $21.92 $1.64
Resistance Level $22.55 $1.74
Average True Range (ATR) 0.48 0.09
MACD -0.01 -0.00
Stochastic Oscillator 40.28 28.85

Price Performance

Historical Comparison
WTBA
LCTX

About WTBA West Bancorporation

West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: